Amarin Corp Plc\Uk (AMRN) EBITDA Margin (2013 - 2026)
Amarin Corp Plc\Uk (AMRN) posted EBITDA Margin of -26.94% for Q2 2026, down 5.97 percentage points from -20.97% a year earlier and down 3.24 percentage points from the prior quarter.
Powered by 
Analysis
Amarin Corp Plc\Uk (AMRN) EBITDA Margin (2013 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, EBITDA Margin at Amarin Corp Plc\Uk was -20.37%, up 28.63 percentage points year-over-year; for FY2025, it was -22.07%, up 16.77 percentage points from FY2024.
- Annual EBITDA Margin shows a five-year change of -19.20 percentage points (FY2020 to FY2025).
- In prior years, Amarin Corp Plc\Uk's EBITDA Margin was -38.84% in FY2024 (-17.78 pp), -21.06% in FY2023 (+6.78 pp), -27.84% in FY2022 (-30.13 pp) and 2.29% in FY2021 (+5.16 pp).
- The Q2 2026 figure stands as the lowest quarterly EBITDA Margin since Q1 2025.
- On a year-over-year basis, EBITDA Margin increased in three of the last eight quarters, with an average year-over-year change of -2.94 percentage points.
- The strongest year-over-year quarter for EBITDA Margin in the past five years was Q4 2025, with a gain of 71.69 percentage points; the weakest was Q4 2024, with a drop of 77.62 percentage points.
- According to Business Quant data, EBITDA Margin for the three prior quarters was -23.70% (Q1 2026), -11.42% (Q4 2025) and -20.61% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 35.95% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 49.01% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 6.02% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 33.11% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 46.01% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -124.26% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 39.16% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 39.10% |
| 10 | Amarin Corp Plc\Uk | 5.57 Bn | 4.35 Bn | 14.99 Mn | -26.94% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -26.94% |
| Mar 31, 2026 | -23.70% |
| Dec 31, 2025 | -11.42% |
| Sep 30, 2025 | -20.61% |
| Jun 30, 2025 | -20.97% |
| Mar 31, 2025 | -38.14% |
| Dec 31, 2024 | -83.11% |
| Sep 30, 2024 | -57.72% |
| Jun 30, 2024 | 0.35% |
| Mar 31, 2024 | -22.68% |
| Dec 31, 2023 | -5.49% |
| Sep 30, 2023 | -31.36% |
| Jun 30, 2023 | -28.97% |
| Mar 31, 2023 | -19.28% |
| Dec 31, 2022 | -9.78% |
| Sep 30, 2022 | -4.86% |
| Jun 30, 2022 | -65.70% |
| Mar 31, 2022 | -29.09% |
| Dec 31, 2021 | 11.71% |
| Sep 30, 2021 | -8.65% |
API Access
Amarin Corp Plc\Uk EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=AMRN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "AMRN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=AMRN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();